Aberdeen Group’s Veracyte VCYT Stock Holding History

Aberdeen Group’s Portfolio VCYT Stock Details VCYT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-162,102	Closed	-$5.56M	–	990
2025 Q3	$5.56M	Sell	162,102 -19,821	-11%	-$569K	0.01%	690
2025 Q2	$4.92M	Buy	+181,923	New	+$5.27M	0.01%	708
2019 Q4	–	Sell	-11,085	Closed	-$266K	–	953
2019 Q3	$266K	Buy	+11,085	New	+$295K	﹤0.01%	907

Other funds holding VCYT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Aberdeen Group's VCYT Position: Q4 2025 in Review

Aberdeen Group sold out of Veracyte (VCYT) in Q4 2025, closing a stake of 162,102 shares — an estimated $5.56M sold.

Aberdeen Group first reported a position in VCYT in Q3 2019 and held it in 3 quarters. The position peaked at $5.56M in Q3 2025. 329 funds tracked by Wall St. Rank hold VCYT as of Q4 2025.

Aberdeen Group reported no remaining Veracyte position as of Q4 2025 after selling out during the quarter.
Aberdeen Group sold 162,102 Veracyte shares in Q4 2025, an estimated $5.56M.
Aberdeen Group first reported a position in Veracyte in Q3 2019 and held it in 3 quarters.
Aberdeen Group's Veracyte position peaked at $5.56M in Q3 2025.
329 funds tracked by Wall St. Rank held Veracyte as of Q4 2025.

Based on Aberdeen Group's 13F filing for Q4 2025, filed 16 Jan 2026.